Rare jobs in Hitchin - Page 2Create job alerts

We are seeking a talentedSenior analystto join our growing team to support our product-building capabilitieswithin our rare earth research and consultancy.

Reporting to the Medical Asset Lead, you will play a key role in shaping the clinical and scientific narrative, enabling evidence generation, and building trusted partnerships with the rare disease community. Lead the development and implementation of the Global Medical Plan for assigned rare diseas

Architect: Rare Path to Design Management. This role offers ambitious architects the rare opportunity to transition into design management, with full support, mentorship, and structured exposure to some of the industry’s most complex and high-value projects (£200m–£1.

A leading biopharmaceutical company is seeking a Global Medical Director to shape the medical strategy for rare diseases.

A global biotechnology company in the United Kingdom is seeking a Global Medical Lead to oversee the Enzyme Conditions portfolio in Medical Affairs.Responsibilities include strategic planning, regulatory engagement, and collaboration across departments.The ideal candidate will have an advanced life

A small, fast-growing biotech in the UK is seeking a Senior Brand Manager for a rare disease launch.

Yard Manager at this experienced Rehabilitation Centre.Moorcroft Equine Rehabilitation Centre in West Sussex.Description Managing the yard to a high standard.Taking care of other staff and working well as a team.A desire to learn, progress and help is so much more important that experience as much c

Cookie NoticeGlobal Medical Director, Rare Diseases page is loaded## Global Medical Director, Rare Diseaseslocations: London (UK): Paristime type: Full timeposted on: Posted Todayjob requisition id: R-20257**Title:Global Medical Director, Rare DiseasesCompany:Ipsen Biopharm LtdAbou

A global biopharmaceutical company in the UK is seeking a Global Medical Director to lead the medical strategy for rare diseases. You will be responsible for driving clinical studies, building partnerships within the rare disease community, and ensuring effective scientific communication. This full-